TY - JOUR
T1 - Changing expectations for neurological outcomes after the neonatal arterial switch operation
AU - Andropoulos, Dean B.
AU - Easley, R. Blaine
AU - Brady, Kenneth Martin
AU - McKenzie, E. Dean
AU - Heinle, Jeffrey S.
AU - Dickerson, Heather A.
AU - Shekerdemian, Lara
AU - Meador, Marcie
AU - Eisenman, Carol
AU - Hunter, Jill V.
AU - Turcich, Marie
AU - Voigt, Robert G.
AU - Fraser, Charles D.
N1 - Funding Information:
Funded in part by NIH NICHD 1R21-HD55501-01 , Charles A. Dana Foundation, and Texas Children's Hospital Anesthesiology Research Fund (D.B.A.).
PY - 2012/10
Y1 - 2012/10
N2 - Background: Expectations for outcomes after the neonatal arterial switch operation (ASO) continue to change. This cohort study describes neurodevelopmental outcomes at age 12 months after neonatal ASO, and analyzes both modifiable and nonmodifiable factors for association with adverse outcomes. Methods: Patients who underwent an ASO (n = 30) were enrolled in a prospective outcome study, with comprehensive clinical data collection during the first 12 months of life. Brain magnetic resonance imaging was done preoperatively and 7 days postoperatively, and the Bayley Scales of Infant Development III was performed at age 12 months. Results: Ten of 30 patients (33%) had preoperative magnetic resonance imaging injury; 13 of 30 patients (43%) had new postoperative magnetic resonance imaging injury. Twenty patients (67%) had Bayley Scales of Infant Development III: Cognitive Composite standard score mean was 104.8 ± 15.0, Language Composite standard score median was 90.0 (25th to 75th percentile, 83 to 94), and Motor Composite standard score mean was 92.3 ± 14.2. Best subsets multivariable analysis found associations between lower preoperative and intraoperative cerebral oxygen saturation, preoperative magnetic resonance imaging brain injury, total bypass time, and total midazolam dose and lower Bayley Scales of Infant Development III scores at age 12 months. Conclusions: At 12 months after ASO, neurodevelopmental outcome means were within normal population ranges. The new associations reported in this study between potentially modifiable perioperative factors and outcomes require investigations in larger patient cohorts. Beyond survival, which was 100% in this cohort, factors influencing quality of life including neurodevelopmental outcomes should be routinely investigated in studies of ASO patients.
AB - Background: Expectations for outcomes after the neonatal arterial switch operation (ASO) continue to change. This cohort study describes neurodevelopmental outcomes at age 12 months after neonatal ASO, and analyzes both modifiable and nonmodifiable factors for association with adverse outcomes. Methods: Patients who underwent an ASO (n = 30) were enrolled in a prospective outcome study, with comprehensive clinical data collection during the first 12 months of life. Brain magnetic resonance imaging was done preoperatively and 7 days postoperatively, and the Bayley Scales of Infant Development III was performed at age 12 months. Results: Ten of 30 patients (33%) had preoperative magnetic resonance imaging injury; 13 of 30 patients (43%) had new postoperative magnetic resonance imaging injury. Twenty patients (67%) had Bayley Scales of Infant Development III: Cognitive Composite standard score mean was 104.8 ± 15.0, Language Composite standard score median was 90.0 (25th to 75th percentile, 83 to 94), and Motor Composite standard score mean was 92.3 ± 14.2. Best subsets multivariable analysis found associations between lower preoperative and intraoperative cerebral oxygen saturation, preoperative magnetic resonance imaging brain injury, total bypass time, and total midazolam dose and lower Bayley Scales of Infant Development III scores at age 12 months. Conclusions: At 12 months after ASO, neurodevelopmental outcome means were within normal population ranges. The new associations reported in this study between potentially modifiable perioperative factors and outcomes require investigations in larger patient cohorts. Beyond survival, which was 100% in this cohort, factors influencing quality of life including neurodevelopmental outcomes should be routinely investigated in studies of ASO patients.
UR - http://www.scopus.com/inward/record.url?scp=84866664577&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84866664577&partnerID=8YFLogxK
U2 - 10.1016/j.athoracsur.2012.04.050
DO - 10.1016/j.athoracsur.2012.04.050
M3 - Article
C2 - 22748448
AN - SCOPUS:84866664577
SN - 0003-4975
VL - 94
SP - 1250
EP - 1256
JO - Annals of Thoracic Surgery
JF - Annals of Thoracic Surgery
IS - 4
ER -